Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRIDE: ECT and Medication for Geriatric Depression
NCT01028508Phase 4Completed
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Start
- Jan 2010
- Primary completion
- Sep 2015
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 4 trial of lithium, venlafaxine in major depressive disorder (MDD), sponsored by Icahn School of Medicine at Mount Sinai. Started Jan 2010; status: completed.
02
Drugs
lithiumvenlafaxine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT01028508.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01028508.